CD4+ Tregs and immune control

被引：329

作者：

Fehérvari, Z

Sakaguchi, S

机构：

[1] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Sakyo Ku, Kyoto 6068507, Japan

[2] RIKEN, Inst Phys & Chem Res, Immunopathol Lab, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan

[3] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Japan

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2004年 / 114卷 / 09期

关键词：

D O I：

10.1172/JCI200434495

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Recent years have seen Tregs become a popular subject of immunological research. Abundant experimental data have now confirmed that naturally occurring CD25(+)CD4(+) Tregs in particular play a key role in the maintenance of self tolerance, with their dysfunction leading to severe or even fatal immunopathology. The sphere of influence of Tregs is now known to extend well beyond just the maintenance of immunological tolerance and to impinge on a host of clinically important areas from cancer to infectious diseases. The identification of specific molecular markers in both human and murine immune systems has enabled the unprecedented investigation of these cells and should prove key to ultimately unlocking their clinical potential.

引用

收藏

页码：1209 / 1217

页数：9

相关论文

共 113 条

[1] Homeostasis of peripheral CD4+ T cells:: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers [J].

Almeida, ARM ;

Legrand, N ;

Papiernik, M ;

Freitas, AA .

JOURNAL OF IMMUNOLOGY, 2002, 169 (09) :4850-4860

[2] In vivo instruction of suppressor commitment in naive T cells [J].

Apostolou, I ;

von Boehmer, H .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) :1401-1408

[3] Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].

Asano, M ;

Toda, M ;

Sakaguchi, N ;

Sakaguchi, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396

[4] An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].

Asseman, C ;

Mauze, S ;

Leach, MW ;

Coffman, RL ;

Powrie, F .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003

[5] Suppressor T cells in human diseases [J].

Baecher-Allan, C ;

Hafler, DA .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) :273-276

[6] CD4+CD25high regulatory cells in human peripheral blood [J].

Baecher-Allan, C ;

Brown, JA ;

Freeman, GJ ;

Hafler, DA .

JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253

[7] In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].

Barrat, FJ ;

Cua, DJ ;

Boonstra, A ;

Richards, DF ;

Crain, C ;

Savelkoul, HF ;

de Waal-Malefyt, R ;

Coffman, RL ;

Hawrylowicz, CM ;

O'Garra, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616

[8] The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 [J].

Bennett, CL ;

Christie, J ;

Ramsdell, F ;

Brunkow, ME ;

Ferguson, PJ ;

Whitesell, L ;

Kelly, TE ;

Saulsbury, FT ;

Chance, PF ;

Ochs, HD .

NATURE GENETICS, 2001, 27 (01) :20-21

[9] Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].

Berg, DJ ;

Davidson, N ;

Kuhn, R ;

Muller, W ;

Menon, S ;

Holland, G ;

ThompsonSnipes, L ;

Leach, MW ;

Rennick, D .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020

[10]

BLAIR PJ, 1994, J IMMUNOL, V153, P3764

← 1 2 3 4 5 6 7 8 9 10 →